De Boer A - Search Results

1

Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

Soons PA, De Boer A, Cohen AF, Breimer DD. Soons PA, et al. Among authors: de boer a. Br J Clin Pharmacol. 1991 Dec;32(6):697-704. Br J Clin Pharmacol. 1991. PMID: 1768562 Free PMC article. Clinical Trial.

2

Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.

de Boer A, Kluft C, Kroon JM, Kasper FJ, Schoemaker HC, Pruis J, Breimer DD, Soons PA, Emeis JJ, Cohen AF. de Boer A, et al. Thromb Haemost. 1992 Jan 23;67(1):83-7. Thromb Haemost. 1992. PMID: 1615490

3

The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.

De Boer A, Stiekema JC, Danhof M, Breimer DD. De Boer A, et al. Br J Clin Pharmacol. 1991 Jul;32(1):23-9. doi: 10.1111/j.1365-2125.1991.tb05608.x. Br J Clin Pharmacol. 1991. PMID: 1716140 Free PMC article.

4

Influence of chlorthalidone on the pharmacokinetics and pharmacodynamics of Org 10172 (Lomoparan), a low molecular weight heparinoid, in healthy volunteers.

de Boer A, Stiekema JC, Danhof M, Breimer DD. de Boer A, et al. J Clin Pharmacol. 1991 Jul;31(7):611-7. doi: 10.1002/j.1552-4604.1991.tb03746.x. J Clin Pharmacol. 1991. PMID: 1716644 Clinical Trial.

5

Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers.

de Boer A, Stiekema JC, Danhof M, Moolenaar AJ, Breimer DD. de Boer A, et al. Eur J Clin Pharmacol. 1991;41(3):245-50. doi: 10.1007/BF00315437. Eur J Clin Pharmacol. 1991. PMID: 1748141 Clinical Trial.

6

Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

De Boer A, Kluft C, Kasper FJ, Kroon JM, Schoemaker HC, Breimer DD, Soons PA, Cohen AF. De Boer A, et al. Br J Clin Pharmacol. 1993 Aug;36(2):99-104. doi: 10.1111/j.1365-2125.1993.tb04203.x. Br J Clin Pharmacol. 1993. PMID: 8398589 Free PMC article. Clinical Trial.

7

Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.

Van Hoogdalem EJ, Wackwitz AT, De Boer AG, Cohen AF, Breimer DD. Van Hoogdalem EJ, et al. Among authors: de boer ag. Br J Clin Pharmacol. 1989 Jan;27(1):75-81. doi: 10.1111/j.1365-2125.1989.tb05337.x. Br J Clin Pharmacol. 1989. PMID: 2706190 Free PMC article. Clinical Trial.

8

Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.

Soons PA, de Boer AG, van Brummelen P, Breimer DD. Soons PA, et al. Among authors: de boer ag. Br J Clin Pharmacol. 1989 Feb;27(2):179-89. doi: 10.1111/j.1365-2125.1989.tb05349.x. Br J Clin Pharmacol. 1989. PMID: 2713213 Free PMC article. Clinical Trial.

9

Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: a study in healthy volunteers.

Burm AG, de Boer AG, van Kleef JW, Vermeulen NP, de Leede LG, Spierdijk J, Breimer DD. Burm AG, et al. Among authors: de leede lg, de boer ag. Biopharm Drug Dispos. 1988 Jan-Feb;9(1):85-95. doi: 10.1002/bod.2510090109. Biopharm Drug Dispos. 1988. PMID: 3342287 Clinical Trial.

10

Absorption enhancement of a hydrophilic model compound by verapamil after rectal administration to rats.

Noach AB, Blom-Roosemalen MC, De Boer AG, Breimer DD. Noach AB, et al. Among authors: de boer ag. J Pharm Pharmacol. 1995 Jun;47(6):466-8. doi: 10.1111/j.2042-7158.1995.tb05832.x. J Pharm Pharmacol. 1995. PMID: 7545750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,398 results

Search Page

Filters